Molecular recognition of protein− ligand complexes: Applications to drug design

RE Babine, SL Bender - Chemical reviews, 1997 - ACS Publications
Advances in molecular biology have had a dramatic impact on the drug discovery process.
1, 2 The ability to produce recombinant proteins of biological significance has greatly …

The pharmacological landscape and therapeutic potential of serine hydrolases

DA Bachovchin, BF Cravatt - Nature reviews Drug discovery, 2012 - nature.com
Serine hydrolases perform crucial roles in many biological processes, and several of these
enzymes are targets of approved drugs for indications such as type 2 diabetes, Alzheimer's …

Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

MD Eldridge, CW Murray, TR Auton, GV Paolini… - Journal of computer …, 1997 - Springer
This paper describes the development of a simple empirical scoringfunction designed to
estimate the free energy of binding for aprotein–ligand complex when the 3D structure of the …

The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

HJ Böhm - Journal of computer-aided molecular design, 1994 - Springer
A new simple empirical function has been developed that estimates the free energy of
binding for a given protein-ligand complex of known 3D structure. The function takes into …

Structure-based design of novel potent nonpeptide thrombin inhibitors

NH Hauel, H Nar, H Priepke, U Ries… - Journal of medicinal …, 2002 - ACS Publications
The clinical syndromes of thromboembolism are evoked by an excessive stimulation of the
coagulation cascade. In this context, the serine protease thrombin plays a key role …

Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs

HJ Böhm - Journal of computer-aided molecular design, 1998 - Springer
A dataset of 82 protein–ligand complexes of known 3D structure and binding constant K i
was analysed to elucidate the important factors that determine the strength of protein–ligand …

Consensus scoring for ligand/protein interactions

RD Clark, A Strizhev, JM Leonard, JF Blake… - Journal of Molecular …, 2002 - Elsevier
Several different functions have been put forward for evaluating the energetics of ligand
binding to proteins. Those employed in the DOCK, GOLD and FlexX docking programs have …

Recent developments in structure-based drug design

G Klebe - Journal of molecular medicine, 2000 - Springer
Structure-based design has emerged as a new tool in medicinal chemistry. A prerequisite for
this new approach is an understanding of the principles of molecular recognition in protein …

A player of many parts: the spotlight falls on thrombin's structure

MT Stubbs, W Bode - Thrombosis research, 1993 - Elsevier
The action of thrombin is central to the processes of thrombosis and haemostasis (1).
Thrombin exhibits both enzymatic and hormone-like properties, that can be both pro-and …

Protease inhibitors in the clinic

G Abbenante, DP Fairlie - Medicinal Chemistry, 2005 - ingentaconnect.com
This review describes the clinical status (based on available information) of experimental
drugs that inhibit enzymes called proteases, or more precisely a sub-class of proteases …